Corrigendum to Efficacy and Safety of Sipjeondaebo-Tang ... · Stem Cells International Hindawi...
2
Corrigendum Corrigendum to (Efficacy and Safety of Sipjeondaebo-Tang for Anorexia in Patients with Cancer: A Pilot, Randomized, Double-Blind, Placebo-Controlled Trial) Chunhoo Cheon , 1 Jeong-Eun Yoo, 2 Hwa-Seung Yoo , 2 Chong-Kwan Cho, 2 Sohyeon Kang, 1 Mia Kim, 3 Bo-Hyoung Jang , 1 Yong-Cheol Shin, 1 and Seong-Gyu Ko 1 1 Department of Preventive Medicine, Korean Medical College, Kyung Hee University, Seoul, Republic of Korea 2 Dunsan Korean Medicine Hospital of Daejeon University, Daejeon, Republic of Korea 3 Department of Cardiovascular and Neurologic Disease (Stroke Center), College of Korean Medicine, Kyung Hee University, Seoul, Republic of Korea Correspondence should be addressed to Seong-Gyu Ko; [email protected] Received 16 May 2018; Accepted 21 June 2018; Published 30 July 2018 Copyright © 2018 Chunhoo Cheon et al. isis an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. In the article titled “Efficacy and Safety of Sipjeondaebo-Tang for Anorexia in Patients with Cancer: A Pilot, Randomized, Double-Blind, Placebo-Controlled Trial” [1], there was an error in the conclusion of the Abstract where the text reading “Sipjeondaebo-tang appears to have potential benefit for anorexia management in patients with cancer. Further large- scale studies are needed to ensure the efficacy” should be corrected to “In the present study, Sipjeondaebo-tang did not show a significant effect on anorexia in patients with cancer. Further large-scale studies which compensate for the limitations of this study are needed to assess the efficacy”. is error in the reporting was brought to the attention of the journal by Professor Edzard Ernst, Emeritus Professor of Complementary Medicine, University of Exeter. e journal and the authors apologize for this misreporting of the conclusions. References [1] C. Cheon, J. Yoo, H. Yoo et al., “Efficacy and Safety of Sipjeondaebo-Tang for Anorexia in Patients with Cancer: A Pilot, Randomized, Double-Blind, Placebo-Controlled Trial,” Evidence-Based Complementary and Alternative Medicine, vol. 2017, Article ID 8780325, 9 pages, 2017. Hindawi Evidence-Based Complementary and Alternative Medicine Volume 2018, Article ID 6162106, 1 page https://doi.org/10.1155/2018/6162106
Transcript of Corrigendum to Efficacy and Safety of Sipjeondaebo-Tang ... · Stem Cells International Hindawi...
CorrigendumCorrigendum to (Efficacy and Safety of Sipjeondaebo-Tangfor Anorexia in Patients with Cancer: A Pilot, Randomized,Double-Blind, Placebo-Controlled Trial)
Chunhoo Cheon ,1 Jeong-Eun Yoo,2 Hwa-Seung Yoo ,2 Chong-Kwan Cho,2
Sohyeon Kang,1 Mia Kim,3 Bo-Hyoung Jang ,1 Yong-Cheol Shin,1 and Seong-Gyu Ko 1
1Department of Preventive Medicine, Korean Medical College, Kyung Hee University, Seoul, Republic of Korea2Dunsan Korean Medicine Hospital of Daejeon University, Daejeon, Republic of Korea3Department of Cardiovascular and Neurologic Disease (Stroke Center), College of Korean Medicine, Kyung Hee University,Seoul, Republic of Korea
Correspondence should be addressed to Seong-Gyu Ko; [email protected]
Received 16 May 2018; Accepted 21 June 2018; Published 30 July 2018
Copyright © 2018 ChunhooCheon et al.This is an open access article distributed under theCreativeCommonsAttribution License,which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
In the article titled “Efficacy and Safety of Sipjeondaebo-Tangfor Anorexia in Patients with Cancer: A Pilot, Randomized,Double-Blind, Placebo-Controlled Trial” [1], there was anerror in the conclusion of the Abstract where the text reading“Sipjeondaebo-tang appears to have potential benefit foranorexia management in patients with cancer. Further large-scale studies are needed to ensure the efficacy” should becorrected to “In the present study, Sipjeondaebo-tang didnot show a significant effect on anorexia in patients withcancer. Further large-scale studies which compensate for thelimitations of this study are needed to assess the efficacy”.
This error in the reporting was brought to the attention ofthe journal by Professor Edzard Ernst, Emeritus Professor ofComplementary Medicine, University of Exeter. The journaland the authors apologize for this misreporting of theconclusions.
References
[1] C. Cheon, J. Yoo, H. Yoo et al., “Efficacy and Safety ofSipjeondaebo-Tang for Anorexia in Patients with Cancer: APilot, Randomized, Double-Blind, Placebo-Controlled Trial,”Evidence-Based Complementary and Alternative Medicine, vol.2017, Article ID 8780325, 9 pages, 2017.
HindawiEvidence-Based Complementary and Alternative MedicineVolume 2018, Article ID 6162106, 1 pagehttps://doi.org/10.1155/2018/6162106
Stem Cells International
Hindawiwww.hindawi.com Volume 2018
Hindawiwww.hindawi.com Volume 2018
MEDIATORSINFLAMMATION
of
EndocrinologyInternational Journal of
Hindawiwww.hindawi.com Volume 2018
Hindawiwww.hindawi.com Volume 2018
Disease Markers
Hindawiwww.hindawi.com Volume 2018
BioMed Research International
OncologyJournal of
Hindawiwww.hindawi.com Volume 2013
Hindawiwww.hindawi.com Volume 2018
Oxidative Medicine and Cellular Longevity
Hindawiwww.hindawi.com Volume 2018
PPAR Research
Hindawi Publishing Corporation http://www.hindawi.com Volume 2013Hindawiwww.hindawi.com
The Scientific World Journal
Volume 2018
Immunology ResearchHindawiwww.hindawi.com Volume 2018
Journal of
ObesityJournal of
Hindawiwww.hindawi.com Volume 2018
Hindawiwww.hindawi.com Volume 2018
Computational and Mathematical Methods in Medicine
Hindawiwww.hindawi.com Volume 2018
Behavioural Neurology
OphthalmologyJournal of
Hindawiwww.hindawi.com Volume 2018
Diabetes ResearchJournal of
Hindawiwww.hindawi.com Volume 2018
Hindawiwww.hindawi.com Volume 2018
Research and TreatmentAIDS
Hindawiwww.hindawi.com Volume 2018
Gastroenterology Research and Practice
Hindawiwww.hindawi.com Volume 2018
Parkinson’s Disease
Evidence-Based Complementary andAlternative Medicine
Volume 2018Hindawiwww.hindawi.com
Submit your manuscripts atwww.hindawi.com
